22 completed. 22 Phase 1, 9 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 22 | Completed 22 |
| Phase 2 | 9 | Completed 9 |
Follow Uveitis: new trials by email Literature Review of Uveitis trials Research Report on Uveitis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety, Tolerability, and Distribution of Laquinimod Eye Drops : The LION Study Laquinimod eye drops - Inflammation, Uveitis | Phase 1 | Completed | Quan Dong Nguyen | 10 | 2024-05-03 | 2026-11-02 |
| Oftac Eye Drops (0.05% Tacrolimus Ophthalmic Emulsion) for the Treatment of Active Non-infectious Anterior Uveitis Oftac: 0.05% tacrolimus ophthalmic emulsion - Non-Infectious Anterior Uveitis | Phase 1 / Phase 2 | Completed | BioNanoSim Ltd. | 18 | 2024-03-07 | 2026-10-13 |
| Evaluation of EYS606 in Patients With Non-infectious Posterior, Intermediate or Panuveitis pEYS606 - Non-infectious Uveitis | Phase 1 / Phase 2 | Completed | Eyevensys | 15 | 2017-04-04 | 2022-03-10 |
| Safety and Efficacy Study of DSP-Visulex for the Treatment of Anterior Uveitis 8% Dexamethasone Sodium Phosphate - Visulex, 15% Dexamethasone Sodium Phosphate - Visulex, Prednisolone Acetate (1%) Eye Drops - Non-Infectious Anterior Uveitis | Phase 1 / Phase 2 | Completed | Aciont Inc | 44 | 2014-10-01 | 2017-04-27 |
| Safety Study of Suprachoroidal Triamcinolone Acetonide Via Microneedle to Treat Uveitis triamcinolone acetonide (Triesence®) - Uveitis, Intermediate Uveitis | Phase 1 / Phase 2 | Completed | Clearside Biomedical, Inc. | 11 | 2013-02-01 | 2021-02-21 |
| Intravitreal Infliximab in Refractory Uveitis in Behcet's Disease: A Safety and Efficacy Clinical Study Intravitreal Infliximab - Behçet's Disease, Uveitis | Phase 1 / Phase 2 | Completed | Cairo University | 20 | 2013-01-01 | 2015-12-03 |
| Anakinra for Behcet s Disease Anakinra - Autoimmune Connective Tissue Disorder, Immune System Diseases | Phase 1 / Phase 2 | Completed | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) | 6 | 2011-09-01 | 2017-05-12 |
| Topical Interferon Gamma for Macular Edema Secondary to Uveitis Interferon Gamma-1b - Anterior Uveitis, Uveitis | Phase 1 / Phase 2 | Completed | National Eye Institute (NEI) | 5 | 2011-06-01 | 2012-10-08 |
| Optiquel® as Corticosteroid-sparing Therapy for Chronic Noninfectious Uveitis B27PD, Placebo - Uveitis | Phase 1 / Phase 2 | Completed | National Eye Institute (NEI) | 31 | 2010-08-01 | 2018-09-11 |
| The Treatment of Uveitic Cystoid Macular Edema With Topical Interferon Gamma Interferon Gamma 1-b - Uveitis | Phase 1 | Completed | National Eye Institute (NEI) | 5 | 2009-07-17 | 2017-07-02 |
| Sirolimus as Therapeutic Approach to Uveitis Sirolimus (rapamycin) - Uveitis, Intermediate Uveitis | Phase 1 | Completed | Johns Hopkins University | 30 | 2009-07-01 | 2018-08-20 |
| Subconjunctival Sirolimus for the Treatment of Autoimmune Active Anterior Uveiti Sirolimus - Anterior Uveitis | Phase 1 | Completed | National Eye Institute (NEI) | 5 | 2009-04-01 | 2017-07-02 |
| Pilot Study of Ranibizumab (Lucentis) for Uveitic Cystoid Macular Edema ranibizumab - Uveitic Cystoid Macular Edema | Phase 1 | Completed | University of Miami | 6 | 2008-06-01 | 2014-08-26 |
| Lucentis for Inflammatory Macular Edema Trial Ranibizumab - Uveitis, Cytoid Macular Edema | Phase 1 / Phase 2 | Completed | University of California, San Francisco | 7 | 2007-07-01 | 2017-11-30 |
| Prophylactic Anecortave Acetate in Patients With a Retisert Implant anecortave acetate - Uveitis, Posterior, Glaucoma | Phase 1 | Completed | Texas Retina Associates | 12 | 2006-09-01 | 2012-06-05 |
| Efalizumab to Treat Uveitis Efalizumab - Uveitis, Macular Edema | Phase 1 | Completed | National Eye Institute (NEI) | 6 | 2006-01-01 | 2011-02-02 |
| Intravitreal v. Sub-tenon Injections of Triamcinolone Acetonide for Macular Edema in Retinal Disorders Triamcinolone Acetonide - Macular Degeneration, Retinal Vein Occlusion | Phase 1 | Completed | National Eye Institute (NEI) | 120 | 2005-01-05 | 2017-07-02 |
| Daclizumab and Sirolimus to Treat Uveitis Daclizumab - Uveitis | Phase 1 | Completed | National Eye Institute (NEI) | 6 | 2004-03-03 | 2017-07-02 |
| Vitamin E to Treat Uveitis-Associated Macular Edema Vitamin E - Cystoid Macular Edema, Uveitis | Phase 1 | Completed | National Eye Institute (NEI) | 80 | 2001-07-01 | 2008-03-04 |
| Cyclosporin Implant to Treat Uveitis Cyclosporin A Implant - Eye Disease, Inflammation | Phase 1 | Completed | National Eye Institute (NEI) | 10 | 1998-05-01 | 2008-03-04 |
Showing 20 of 22. Sign in to see all of them.
Inflammation (6) · Macular Edema (6) · Uveitis, Intermediate (4) · Uveitis, Posterior (4) · Uveitis, Anterior (3) · Behcet Syndrome (2) · Panuveitis (2) · Retinal Diseases (2) · Arthritis, Juvenile (1) · Autoimmune Diseases (1) · Choroidal Effusions (1) · Choroidal Neovascularization (1) · Diabetes Mellitus, Insulin-Dependent, 10 (1) · Diabetic Retinopathy (1)
Uveal Diseases (22) · Eye Diseases (21) · Panuveitis (7) · Pathologic Processes (6) · Pathological Conditions, Signs and Symptoms (6) · Retinal Degeneration (6) · Macular Degeneration (5) · Cardiovascular Diseases (4) · Retinal Diseases (4) · Skin and Connective Tissue Diseases (4) · Vascular Diseases (4) · Immune System Diseases (3) · Skin Diseases (3) · Skin Diseases, Vascular (3) · Uveitis, Anterior (3)
Daclizumab (2) · Ranibizumab (2) · Sirolimus (2) · Triamcinolone Acetonide (2) · Adrenal Cortex Hormones (1) · Cyclosporine (1) · Interferon-gamma (1) · Interleukin 1 Receptor Antagonist Protein (1) · Ophthalmic Solutions (1) · Triamcinolone (1) · Vitamin E (1) · anecortave acetate (1) · efalizumab (1) · interferon gamma-1b (1) · prednisolone acetate (1)
National Eye Institute (NEI) (11) · Aciont Inc (1) · BioNanoSim Ltd. (1) · Cairo University (1) · Clearside Biomedical, Inc. (1) · Eyevensys (1) · Johns Hopkins University (1) · National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) (1) · Quan Dong Nguyen (1) · Texas Retina Associates (1) · University of California, San Francisco (1) · University of Miami (1)
United States (19) · France (1) · Israel (1) · United Kingdom (1)
David G Callanan, MD (1) · Hatice Nida Sen, MD, MHSc (1) · Mahmoud Soliman, MD PhD (1) · Michal Kramer, MD (1) · Nisha Acharya, MD MS (1) · Peter C Grayson, M.D. (1) · Quan D Nguyen, MD, MSc (1) · Robert B Nussenblatt, M.D. (1) · Robert Nussenblatt, MD, MPH (1) · Thomas A Albini, MD (1) · Thomas Ciulla, MD (1) · William I Higuchi, PhD (1)
PMID 21498606, PMID 21913066, PMID 22465364, PMID 25918559, PMID 27980877, PMID 28335798, PMID 30009894, PMID 39531369, PMID 42211725
R44EY014772 (1)